IP Library › Granted Patent US 10,518,071
Granted Patent B2
US 10,518,071 · App. 15/387,796 · Granted Dec 31, 2019

Transdermal microneedle drug delivery device and method

Inventor: Gajanan Kulkarni (Toronto, CA)
Assignee: Gajanan Kulkarni
A61M37/0015A61M5/14248A61M5/20A61M2005/14252A61M2037/0023A61M2037/0061A61M2202/048A61M2205/59
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,518,071
App. No.
15/387,796
Granted
Dec 31, 2019
Kind
B2
Abstract

A transdermal drug delivery device comprises: a reservoir for holding a drug; and at least one microneedle in fluid communication with the reservoir through which the drug can be delivered transdermally, wherein the transdermal drug delivery device is concealed from view during operation thereof.

Claims (20)

1. A transdermal drug delivery device comprising:

a reservoir for holding a drug;

at least one microneedle in fluid communication with the reservoir through which the drug can be delivered transdermally;

a housing surrounding the reservoir;

a fastening element configured to conceal the housing from view during operation thereof;

an injection unit housed within the housing, wherein the injection unit comprises a bottom cap; and

an actuator for deploying the at least one microneedle, wherein the bottom cap comprises a first indentation or void with a first positon and a second indentation or void with a second position relative to the first position and wherein the first indentation or void lockingly engages one of a pair of protuberances on the actuator before actuation of the at least one microneedle and the second indentation or void locking engages with one of the pair of protuberances on the actuator after actuation of the at least one microneedle.

2. The transdermal drug delivery device of claim 1 , wherein the reservoir is rigid.

3. The transdermal drug delivery device of claim 1 , further comprising a plunger for delivering the drug from the reservoir through the at least one microneedle.

4. The transdermal delivery device of claim 1 , wherein the at least one microneedle is one microneedle.

5. The transdermal delivery device of claim 1 , wherein the fastening element is attachable to the housing, configured for securing the transdermal delivery device to a wearer, and comprises ornamentation selected so as to appeal to a child.

6. The transdermal delivery device of claim 1 , further comprising connecting tubing in fluid communication with the reservoir and the at least one microneedle.

7. The transdermal delivery device of claim 1 , wherein device is remotely operable and operably coupled to a portable base unit for delivering the drug and/or deploying the at least one microneedle.

8. The transdermal delivery device of claim 1 , wherein the device is automated.

9. The transdermal drug delivery device of claim 1 , comprising more than one reservoir.

10. The transdermal delivery device of claim 1 , wherein movement of the pair of protuberances before and after actuation alerts a user that the at least one microneedle has been ejected from the housing.

11. The transdermal delivery device of claim 1 , wherein the bottom cap has a trough for application for a topical anesthetic and/or analgesic.

12. A method of delivering a drug transdermally, the method comprising expelling a drug from the reservoir of the transdermal drug delivery device of claim 1 through the at least one microneedle and into the skin of a subject.

13. The method of claim 12 , for sedating a subject.

14. The method of claim 12 , wherein the subject is a child.

Continuity (2)
Provisional Application 62272320 · Dec 29, 2015
Related Publication 20170182300A1 · Jun 29, 2017
Cited By (3)
US 12,214,346 US 12,440,133 US 12,446,810